Improving the Effectiveness of Breast Cancer Multidisciplinary Team Meetings in Australia: A Survey-Based Analysis
A/Prof Sanjay Warrier, dr Chu Luan Nguyen | Chris O'Brien Lifehouse Breast Surgery Research
Overview
This study aims to explore clinician perspectives on MDT meeting effectiveness and potential reforms, including openness to artificial intelligence (AI)-assisted solutions. Findings will inform the design of an AI-guided Virtual MDT meeting platform to triage simple cases, reduce workload, and preserve time for complex discussions.
about the survey
You are invited to consider participating in a research study titled “Improving the Effectiveness of Breast Cancer Multidisciplinary Team Meetings in Australia: A Survey-Based Analysis”, conducted by the Breast Surgery Unit, Chris O’Brien Lifehouse.
Participation involves completing an anonymous online survey of 30 questions (Likert scales, yes/no, and free-text). It will take 15-20 minutes and can be saved and resumed later. Submitting the completed survey indicates your consent. Participation is voluntary.
Breast cancer MDT meetings face growing pressures from rising case volumes and complexity, leading to inefficiencies. International guidance supports streamlining and protocolised pathways, yet evidence on feasibility in Australia is lacking. This survey aims to explore clinician perspectives on current MDT practices and potential improvements, as part of our preliminary work toward integrating artificial intelligence (AI) into MDT workflows.
The survey was adapted from the Cancer Research UK MDT Effectiveness Study. Ethics approval was granted by the institutional review board. If you would like more information before deciding, please contact Dr Chu Nguyen (coordinating investigator) on 0401 608 581 or email [email protected].
Thank you for considering this invitation.
more information:
Contact: Dr Chu Nguyen (coordinating investigator) on 0401 608 581 or email [email protected].
Ethics: Royal Prince Alfred Hospital [HREC application 2025/ETH02580.]
Access to this survey expires: 20 May 2026.